Gene · 4014
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topical Calcineurin Inhibitors and the Epidermal Barrier in Atopic Dermatitis. | Dermatology | 2026 | 42149786 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Polyphenols in Modulating Barrier Lipids, Microbiome Interactions, and Inflammatory Pathways in Atopic Dermatitis. | Nutrients | 2026 | 42123967 | PubTator, text mining | PubMed |
| Cold atmospheric plasma ameliorating skin barrier in chronic kidney disease. | NPJ Regen Med | 2026 | 42120388 | PubTator, text mining | PubMed |
| Lysine Carboxymethyl Cysteinate (LCC) Protects the Epidermis from UVB-Induced Barrier Damage Through the Activation of Autophagy. | Biology (Basel) | 2026 | 42041879 | PubTator, text mining | PubMed |
| WITHDRAWN: Neonatal urinary phthalate metabolite concentrations are associated with the development of atopic dermatitis. | Ann Allergy Asthma Immunol | 2026 | 42019625 | PubTator, text mining | PubMed |
| A Spontaneous Novel c.679dupG Mutation in the LOR Gene Resulting in Loricrin Keratoderma with Ichthyosis. | Dermatol Pract Concept | 2026 | 41912209 | PubTator, text mining | PubMed |
| Mechanism of Anticancer Activity of Cedrol in Epidermal Carcinoma Cells and Its Validation in 3D Artificial Skin Model. | J Microbiol Biotechnol | 2026 | 41881674 | PubTator, text mining | PubMed |
| GPER1 reduces skin inflammation by inhibiting keratinocyte proliferation. | Cell Death Discov | 2026 | 41862447 | PubTator, text mining | PubMed |
| Dual-Targeting Oligopeptide-215 Regulates Skin Barrier Homeostasis Through Concurrent Modulation of JAK-STAT and NF-κB Signaling. | J Cosmet Dermatol | 2026 | 41858149 | PubTator, text mining | PubMed |
| Skin Barrier-Improving and Anti-Inflammatory Effects of Exosomes Derived from the Fructobacillus fructosus NSH-1 Strain Isolated from the Campsis grandiflora Flower. | J Microbiol Biotechnol | 2026 | 41821372 | PubTator, text mining | PubMed |
| Efficacy Evaluation of N-Acyl-Phytosphingosine Prepared from Marula Oil Derived Fatty Acids in Skin Barrier Repair. | Clin Cosmet Investig Dermatol | 2026 | 41809528 | PubTator, text mining | PubMed |
| Laryngeal squamous cell carcinoma: a functional "two-hit" model of papillomavirus-Epstein-Barr virus synergistic carcinogenesis. | Front Cell Infect Microbiol | 2026 | 41798741 | PubTator, text mining | PubMed |
| Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis. | Mayo Clin Proc Innov Qual Outcomes | 2026 | 41769322 | PubTator, text mining | PubMed |
| An Overview of the Mechanisms of Fractional CO2 Laser in Scar Treatment. | Lasers Med Sci | 2026 | 41766024 | PubTator, text mining | PubMed |
| Double network crosslinked antibacterial and antioxidant cellulose-based hydrogel capable of healing wound for protecting open abdomen. | Int J Biol Macromol | 2026 | 41765301 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| Anti-Photoaging Effects of a Polysaccharide from Kappaphycus alvarezii In Vitro and In Vivo. | Mar Drugs | 2026 | 41745490 | PubTator, text mining | PubMed |
| TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes. | J Biomed Sci | 2026 | 41742188 | PubTator, text mining | PubMed |
| From basic biology to engineered therapies: the keratinocyte stem cell playbook. | Front Med Technol | 2026 | 41726153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4014/papers?page=2